Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omega Healthcare Investors, Inc. (OHI) SEC Filings & Earnings Calls

EquiReason read 15 Omega Healthcare Investors, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-05 — Omega transitioned 32 skilled nursing facilities in Florida to PACS Group; rent to increase $26.1M in year one, $2.5M in year two, with 2% escalators; one-time expense ~$90M..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OHIOmega Healthcare Investors, Inc.Follow OHI — free
REIT - Healthcare Facilities · Real Estate
—
Price chart with a free account
Market cap
14.0B
P/E TTM
16.5
Dividend yield
5.8%
52-week
—
Next earnings
3 Nov, in 10 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

5 Oct 20268-K · 7.01Omega transitioned 32 skilled nursing facilities in Florida to PACS Group; rent to increase $26.1M in year one, $2.5M in year two, with 2% escalators; one-time expense ~$90M.open

Figures in the filing · each found in the filing text

count_facility · skilled nursing facilities · Q4-202632

Risks flagged

One-time expense of ~$90 million incurred for the transition.

“Omega incurred a one-time expense of approximately $90 million.” · word for word
Read the original on SEC EDGAR ↗
1 Oct 20268-K · 5.02Omega Healthcare Investors appointed Matthew P. Gourmand as President and CEO, succeeding C. Taylor Pickett upon retirement; no disagreement cited.SEC ↗
30 Jul 202610-QOmega Healthcare reported Q2 2026 results: total revenue +16%, net income +166% driven by $246.5M gain on asset sales, but 22.2% of revenue from cash-basis operators signals ongoing tenant distress.earningsopen

Figures in the filing · each found in the filing text

Total Revenues · Q2-2026$328M+16% y/y
Rental Income · Q2-2026$266M+11% y/y
Net Income Available to Common Stockholders · Q2-2026$363M+166% y/y
Diluted EPS · Q2-2026$1.19+159% y/y
Gain on Assets Sold · Q2-2026$247M+977% y/y
Interest Income · Q2-2026$47M+9% y/y
Net Cash Provided by Operating Activities · H1-2026$433M+3% y/y
Total Investments · 2026-06-30$8.61B
Total Debt · 2026-06-30$4.02B

Risks flagged

Operator bankruptcy risk

“In July 2025, Genesis commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code” · word for word

Cash basis revenue concentration

“As of June 30, 2026, we had 22 operators on a cash basis for rental revenue recognition, which represent 22.2% and 17.8% of our total revenues for the six months ended June 30, 2026 and 2025, respectively.” · word for word

Maplewood rent deferral accumulation

“As of June 30, 2026, the outstanding deferred rent balance is $56.6 million.” · word for word

Litigation from Genesis bankruptcy

“The Statutory Unsecured Claimant's Committee has filed a proposed Complaint and Preliminary Objection regarding the collateral supporting our term loans” · word for word
Read the original on SEC EDGAR ↗
29 Jul 20268-K · 2.02Net income $380M (+171% y/y); Adjusted FFO per diluted share $0.83 (+8% y/y); Funds Available for Distribution per diluted share $0.78 (+5% y/y); Guidance: Full-year AFFO guidance midpoint raised to $3.24 (from $3.22).earningsopen

Figures in the filing · each found in the filing text

Net income · Q2-2026$380M+171% y/y
Adjusted FFO per diluted share · Q2-2026$0.83+8% y/y
Funds Available for Distribution per diluted share · Q2-2026$0.78+5% y/y
Net Operating Income · Q2-2026$331M+18% y/y
New investments · Q2-2026$126M
Quarterly dividend per share · Q3-2026$0.68+2% y/y
AFFO guidance midpoint · FY2026$3.24

Guidance

Full-year AFFO guidance midpoint raised to $3.24 (from $3.22).

Raised AFFO guidance driven by strong Q2 results, accretive investments, and favorable operating environment; CEO extremely bullish on outlook.

Risks flagged

Genesis Healthcare bankruptcy exposure: $139.8M principal outstanding under secured term loans and $8.7M DIP financing; rent payments current but risk remains.

“Genesis filed for Chapter 11; Omega received $16.3M paydown on DIP financing; $139.8M principal outstanding under secured term loans.”

Operator concentration risk: significant exposure to Saber Healthcare and other operators; transitions may impact cash flows.

“Expanded partnership with Saber; transitioned 20 facilities from Ciena to Saber.”
Read the original on SEC EDGAR ↗
5 Jun 20268-K · 5.07, 8.01Submitted matters to a vote of security holders; disclosed a material event under other events (litigation, recall, contract loss, or major announcement)SEC ↗
21 May 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open

Risks flagged

Key executive departures may cause short-term uncertainty, but planned succession mitigates risk.

“CEO and CFO departures with transition agreements and consulting arrangements.”
Read the original on SEC EDGAR ↗
29 Apr 202610-QTotal revenues $323M (+17% y/y); Rental income $271M (+17% y/y); Interest income $45M (+5% y/y)open

Figures in the filing · each found in the filing text

Total revenues · Q1-2026$323M+17% y/y
Rental income · Q1-2026$271M+17% y/y
Interest income · Q1-2026$45M+5% y/y
Net income available to common stockholders · Q1-2026$151M+39% y/y
Diluted earnings per share · Q1-2026$0.47+42% y/y
Operating cash flow · Q1-2026$216M+18% y/y
Total debt · Q1-2026$4.44B
Real estate investments · Q1-2026$8.96B
Number of facilities · Q1-2026929
Cash basis operators as % of revenues · Q1-202621.8%

Risks flagged

Operator credit distress (Genesis bankruptcy)

“In July 2025, Genesis commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.” · word for word

High concentration of cash basis operators

“As of March 31, 2026, we had 20 operators on a cash basis for rental revenue recognition, which represent 21.8% of our total revenues.” · word for word

Maplewood liquidity issues

“Maplewood is on a cash basis of revenue recognition for lease purposes and non-accrual status for loan purposes as a result of liquidity issues beginning in 2023.” · word for word

Revolving credit facility drawdown

“Revolving credit facility $425,000 vs $242,000 at December 31, 2025.”
Read the original on SEC EDGAR ↗
28 Apr 20268-K · 2.02Q1 net income $159M vs $112M YoY; AFFO $0.82/share; completed $251M investments; raised AFFO guidance midpoint to $3.22; Genesis DIP financing; 18 facilities to be sold for $480M.earningsopen

Figures in the filing · each found in the filing text

Net Income · Q1-2026$159M+42% y/y
Adjusted FFO per Share · Q1-2026$0.82+9% y/y
Funds Available for Distribution per Share · Q1-2026$0.78+10% y/y
Total Investments · Q1-2026$251M
Rental Income from Genesis · Genesis · Q1-2026$13M
Interest Income from Genesis · Genesis · Q1-2026$7M
Weighted Average Shares Outstanding · Q1-2026315,000,000+7% y/y

Guidance

FY2026 AFFO guidance midpoint raised to $3.22 from $3.20

Raised full year AFFO guidance midpoint by $0.02 to $3.22, reflecting strong Q1 results and accretive investments.

Risks flagged

Genesis bankruptcy exposure: $26.7M DIP financing with $25M funded; rental and interest payments received but risk of default remains.

“Genesis filed for Chapter 11 bankruptcy protection on July 9, 2025... Omega agreed to provide $26.7 million in a new super-priority secured $80.0 million debtor-in-possession financing”

Concentration risk: 18 facilities to be sold for $480M; execution risk on sale and redeployment.

“18 CommuniCare facilities expected to be sold in Q2 for $480 million” · word for word
Read the original on SEC EDGAR ↗
21 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, detailing executive compensation and governance matters.open

Figures in the filing · each found in the filing text

Funds Available for Distribution per share · FY2025$2.96+8% y/y
New Investments · FY2025$1.10B
Tenant Quality · FY202599.7%
Leverage · FY2025$3.50
Absolute TSR (3-year) · FY202523.4%
Relative TSR (3-year) · FY2025$62.90
Say-on-Pay Approval · FY202595.9%
Read the original on SEC EDGAR ↗
9 Feb 202610-KTotal investments $11.94B; Number of facilities 1,111; Revenue from real estate assets $266Mopen

Figures in the filing · each found in the filing text

Total investments · 2025-12-31$11.94B
Number of facilities · 2025-12-311,111
Revenue from real estate assets · Real estate assets · FY2025$266M
Revenue from mortgage loans · Mortgage loans · FY2025$27M
Total revenue · FY2025$313M
Average annualized yield on triple-net leases · 2025-12-3110.4%
Average annualized yield on real estate loans · 2025-12-3110.2%
Average annualized yield on non-real estate loans · 2025-12-3110.2%
Percentage of triple-net leases expiring after 2030 · 2025-12-3186.0%

Risks flagged

Medicaid reimbursement cuts

“The July 2025 passage of the OBBBA enacted significant reforms regarding funding and operation of the Medicaid program, including an estimated $920 billion in cuts to Medicaid over the next decade” · word for word

Operator credit risk

“Most of our SNF operators derive a substantial portion of their revenue from state Medicaid programs.” · word for word

Regulatory and legislative risk

“In addition to concerns noted by CMS regarding the quality of care provided at SNFs owned by private equity firms, REITs and other investment firms, in announcing the final rule, in 2024 and 2025, several U.S. senators proposed legislation that would, if enacted, restrict certain investors, including REITs and private equity firms, from investing in healthca” · word for word
Read the original on SEC EDGAR ↗
4 Feb 20268-K · 2.02Net income $172M (+48% y/y); Adjusted FFO per diluted share $0.80 (+8% y/y); FAD per diluted share $0.76 (+9% y/y); Guidance: 2026 Adjusted FFO guidance provided, implying continued growth trajectory.earningsopen

Figures in the filing · each found in the filing text

Net income · Q4-2025$172M+48% y/y
Adjusted FFO per diluted share · Q4-2025$0.80+8% y/y
FAD per diluted share · Q4-2025$0.76+9% y/y
New investments · Q4-2025$334M
Weighted-average common shares outstanding · Q4-2025313,000,000+9% y/y
Total debt repaid · Q4-2025$1.27B
Net income per diluted share · Q4-2025$0.55+34% y/y
FAD per share (full year) · FY2025$2.96+8% y/y
AFFO per diluted share (full year) · FY2025$3.10+8% y/y
Net income (full year) · FY2025$609M+46% y/y

Guidance

2026 Adjusted FFO guidance provided, implying continued growth trajectory.

Omega provides 2026 Adjusted FFO guidance with positive outlook, citing strong operating metrics, active pipeline, and strong balance sheet. CEO expresses confidence in continued accretive investment.

Risks flagged

Operator bankruptcy risk: Genesis Healthcare filed for Chapter 11, but continues to make payments.

“Genesis Healthcare, Inc. filed for Chapter 11 bankruptcy protection on July 9, 2025. Since filing, Genesis has made all required contractual rent and interest payments through January 2026.”

Share dilution from equity issuance: 5.5 million OP units and 16 million common shares issued in 2025.

“Issued 16 million common shares and 5.5 million Omega OP Units for proceeds/value of $612 million and $222 million, respectively.” · word for word
Read the original on SEC EDGAR ↗
7 Jan 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
3 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen

Risks flagged

Potential dilution from ATM offering; no specific amount disclosed.

“At-the-Market Equity Offering Sales Agreement” · word for word
Read the original on SEC EDGAR ↗
31 Oct 202510-QOmega Healthcare reported strong revenue and net income growth, but operator distress persists.earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q3-2025$312M+13% y/y
Net income available to common stockholders · Q3-2025$180M+61% y/y
Diluted EPS · Q3-2025$0.59+41% y/y
Rental income · Q3-2025$265M+14% y/y
Interest income · Q3-2025$45M+12% y/y
Operating cash flow · 9M-2025$648M+25% y/y
Investments in real estate · Q3-2025$8.65B

Risks flagged

Operator credit risk

“Maplewood short-paid contractual rent and interest; Genesis filed Chapter 11; 20 operators on cash basis.”

Concentration risk

“Maplewood and Genesis represent significant portions of revenue and loans.”

Bankruptcy risk

“Genesis commenced Chapter 11 in July 2025.”
Read the original on SEC EDGAR ↗
30 Oct 20258-K · 2.02Net income $185M (+61% y/y); Adjusted FFO per diluted share $0.79 (+7% y/y); FAD per diluted share $0.75 (+7% y/y); Guidance: AFFO per share raised from $2.90-$2.98 to $3.08-$3.10earningsopen

Figures in the filing · each found in the filing text

Net income · Q3-2025$185M+61% y/y
Adjusted FFO per diluted share · Q3-2025$0.79+7% y/y
FAD per diluted share · Q3-2025$0.75+7% y/y
New investments · Q3-2025$151M
AFFO guidance (full year) · FY2025$3.09

Guidance

AFFO per share raised from $2.90-$2.98 to $3.08-$3.10

Full-year AFFO guidance raised on strong Q3 results, active investment pipeline, and improving operating metrics.

Risks flagged

Operator bankruptcy risk (Genesis) with DIP financing exposure.

“Genesis Healthcare, Inc. filed for Chapter 11 bankruptcy protection on July 9, 2025. Company provided $8.0M debtor-in-possession financing.”
Read the original on SEC EDGAR ↗

Omega Healthcare Investors, Inc. — questions

What did Omega Healthcare Investors, Inc. file recently?
15 SEC filings in the last 12 months. Latest: 8-K on 2026-10-05 — Omega transitioned 32 skilled nursing facilities in Florida to PACS Group; rent to increase $26.1M in year one, $2.5M in year two, with 2% escalators; one-time expense ~$90M.

Every figure on this page comes from Omega Healthcare Investors, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.